Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Tuberculosis 1Sarcoidosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Infections 1Graft vs Host Disease 1Congenital Abnormalities 1

Interventions

Cyclosporine 5Cyclophosphamide 5Busulfan 4fludarabine phosphate 3fludarabine 3Mycophenolic Acid 3thymoglobulin 2Methotrexate 2Drug Therapy 2Antilymphocyte Serum 2venetoclax 1trihexyltetradecylphosphonium chloride 1treosulfan 1tocilizumab 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Sirolimus 1Semustine 1Rituximab 1Radiotherapy 1Polymerase Chain Reaction 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Maraviroc 1Interferon alpha-2 1Immunoenzyme Techniques 1Decitabine 1Cytarabine 1Cyclosporins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Graft vs Host Disease × Bronchoalveolar Lavage × Clear all
NCT00462657 2013-08-26

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

National Cancer Institute (NCI)

Phase NA Unknown
200 enrolled
LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Infections, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡